Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Jynneos Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The expansion observed during the historical timeframe was primarily due to worldwide initiatives aimed at eradicating smallpox, preceding monkeypox outbreaks, the creation of more secure vaccinia platforms, governmental readiness strategies, and public health immunization campaigns.
The expansion observed throughout the forecast period is due to factors such as escalating zoonotic disease threats, the enlargement of national vaccine supplies, increased financial support for biodefense, enhancements in global surveillance networks, and wider adult vaccination campaigns. Significant developments anticipated during this period encompass a stronger emphasis on preventing newly emerging infectious diseases, the proliferation of non-replicating vaccine technologies, the scaling up of governmental immunization programs, a surge in the strategic stockpiling of vaccines, and heightened public awareness concerning zoonotic illnesses.
Get A Free Sample Report With In-Depth Market Insights:
Jynneos Market Growth Backed By Core Demand Fundamentals
The increasing incidence of monkeypox cases is anticipated to drive the Jynneos market’s expansion. Monkeypox is a viral illness caused by the monkeypox virus, a member of the orthopoxvirus family. Cases of monkeypox arise due to heightened global travel and greater interaction between wildlife and humans, which facilitates the rapid transmission of infectious agents and transforms isolated outbreaks. Jynneos offers benefits for monkeypox cases as it effectively prevents the virus in at-risk individuals and provides a safer option for those with weakened immune systems compared to traditional smallpox vaccines. For example, in September 2024, the European Centre for Disease Prevention and Control, a Europe-based government agency, reported that from January 2022 to July 2024, over 100,000 confirmed cases of pox attributed to monkeypox virus (MPXV) clade I and clade II, along with over 200 deaths, were documented by more than 120 countries globally. Consequently, the rising number of monkeypox cases is stimulating the growth of the Jynneos market.
Jynneos Market Driver: Development Of Combined Vaccines To Enhance Public Health Preparedness
The principal company operating in the Jynneos market is concentrating on creating combined vaccines designed to address multiple disease targets simultaneously. Combined vaccines are immunizations that provide protection against several diseases with a single injection, thereby reducing the total number of shots required for full immunity. As an illustration, in August 2024, Bavarian Nordic A/S, a Denmark-based biotechnology company, announced that Singapore’s Health Sciences Authority (HSA) had granted approval for JYNNEOS (MVA-BN) for the prevention of smallpox and pox in adults aged 18 and older who are considered at high risk for these infections. JYNNEOS (MVA-BN) is a non-replicating vaccine formulated to offer a safer alternative for individuals, including those with compromised immune systems. Its development aimed to improve public health readiness and confront nascent infectious diseases.
Jynneos Market Segment Analysis And Revenue Potential
The jynneos market covered in this report is segmented –
1) By Indication: Prevention of Monkeypox, Prevention of Smallpox
2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution
3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations
4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers
Jynneos Market Key Players Shaping Industry Direction
Major companies operating in the jynneos market are Bavarian Nordic A/S
View The Full Jynneos Market Report:
Jynneos Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
